Master CDX Agreement Sample Contracts

MASTER CDX AGREEMENT Dated 19 September, 2018 between Merck KGaA and

Master CDX Agreement • June 5th, 2020 • ArcherDX, Inc. • In vitro & in vivo diagnostic substances

• Contract Type
  Master CDX Agreement
• Filed
  June 5th, 2020
• Company
  ArcherDX, Inc.
• Industry
  In vitro & in vivo diagnostic substances

This Master CDx Agreement (this “Agreement”) is dated as of 19 September, 2018 (the “Effective Date”) by and between ArcherDX, Inc., a corporation organized under the laws of the State of Delaware having a place of business at 2477 55th Street, Suite 202, Boulder, CO 80301, United States of America (“ArcherDX”), and Merck KGaA, a corporation with general partners organized under German law having a place of business at Frankfurter Straße 250, 64293 Darmstadt, Germany (“MRK”). ArcherDX and MRK may be referred to herein as a “Party” or, collectively, as “Parties”.